Clinical trials recruiting for Relapsing Remitting Multiple Sclerosis

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
  NCT05906992 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
  NCT04047628 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 23 locations
• Investigation of Subclinical Markers of Multiple Sclerosis
  NCT04604041 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
  NCT05758831 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 23 locations
• Rituximab and Ocrelizumab in Serum With Multiple Sclerosis
  NCT06663111 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
  NCT03783416 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• The HIt HArd and hiT Early in Multiple Sclerosis Trial
  NCT07517185 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 4 locations
• The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
  NCT06796504 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 60 Years · Sex: All (male and female) · 9 locations
• Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
  NCT06586177 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Relapsing Remitting Multiple Sclerosis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Relapsing Remitting Multiple Sclerosis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.